Relator Awarded 15 Percent Of $59M In Settlements For Victoza Diabetes Drug

Mealey's (September 18, 2019, 9:12 AM EDT) -- WASHINGTON, D.C. — A District of Columbia federal judge on Sept. 11 said one relator is entitled to 15 percent of three settlements totaling $59 million but held off payment until after four other purported relators appeal the denial of their claims (United States, et al., ex rel. Lesley Ferrara, et al. v. Novo Nordisk, Inc., et al., No. 13-1529, D. D.C., 2019 U.S. Dist. LEXIS 154547)....

Attached Documents

Related Sections